Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enveric Biosciences

1.73
+0.09005.49%
Post-market: 1.72-0.0100-0.58%19:46 EDT
Volume:85.84K
Turnover:146.93K
Market Cap:3.30M
PE:-0.07
High:1.78
Open:1.69
Low:1.63
Close:1.64
Loading ...

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

TipRanks
·
14 Mar

Enveric Biosciences Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Mar

BRIEF-Enveric Biosciences Says Regains Compliance With Nasdaq Bid Price Rule

Reuters
·
07 Mar

Enveric Biosciences launches RFP solicitation process for PsyAI trademark

TIPRANKS
·
06 Mar

Enveric Biosciences Inc: Period for Receiving Rfps Will Remain Open Until August 31

THOMSON REUTERS
·
06 Mar

Enveric Biosciences Launches Request-for-Proposals Solicitation Process for Psyai Trademark

THOMSON REUTERS
·
06 Mar

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

Business Wire
·
06 Mar

Enveric Biosciences Inc - Regains Compliance With Nasdaq Bid Price Rule

THOMSON REUTERS
·
06 Mar

Enveric Biosciences CEO Issues Letter to Shareholders

Business Wire
·
27 Feb

Upcoming Nvidia Earnings in Spotlight, Lifting US Equity Futures Pre-Bell

MT Newswires Live
·
26 Feb

Enveric Biosciences Prepares Presentation for February 2025

TIPRANKS
·
26 Feb

Top Premarket Gainers

MT Newswires Live
·
26 Feb

US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert

Benzinga
·
26 Feb

Enveric Biosciences Unveils EVM401 Series of Compounds with New U.S. Patent

Business Wire
·
26 Feb

Enveric Biosciences Inc - Milestone Payments Could Total $21 Million for Non-Pharmaceutical License

THOMSON REUTERS
·
04 Feb

Enveric Biosciences and Restoration Biologics Announce Licensing Agreements to Treat Joint Disease

THOMSON REUTERS
·
04 Feb